Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

G Middleton, P Silcocks, T Cox, J Valle, J Wadsley, D Propper, F Coxon, P Ross, S Madhusudan, T Roques, D Cunningham, S Falk, N Wadd, M Harrison, P Corrie, T Iveson, Robinson A Anus, K McAdam, M Eatock, J EvansC Archer, T Hickish, A Garcia-Alonso, M Nicolson, W Steward, A Anthoney, W Greenhalf, V Shaw, E Costello, D Naisbitt, R Rawcliffe, G Nanson, J Neoptolemos

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)829-840
    Number of pages11
    JournalThe Lancet Oncology
    Issue number8
    Publication statusPublished - Jul 2014

    Cite this